Familial hypercholesterolemia: case series of a rare condition

Introduction. Cardiovascular events at a young age are often the first manifestation of a genetic disorder such as familial hypercholesterolemia. High cholesterol levels, xanthomas and xanthelasmas, as well as a positive family history of cardiovascular disease, make it possible to identify a group...

Full description

Bibliographic Details
Main Authors: O. P. Ishevskaia, A. M. Namitokov, S. V. Kruchinova, E. D. Kosmacheva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4610
_version_ 1797856652004687872
author O. P. Ishevskaia
A. M. Namitokov
S. V. Kruchinova
E. D. Kosmacheva
author_facet O. P. Ishevskaia
A. M. Namitokov
S. V. Kruchinova
E. D. Kosmacheva
author_sort O. P. Ishevskaia
collection DOAJ
description Introduction. Cardiovascular events at a young age are often the first manifestation of a genetic disorder such as familial hypercholesterolemia. High cholesterol levels, xanthomas and xanthelasmas, as well as a positive family history of cardiovascular disease, make it possible to identify a group of patients subject to genetic research. The identification of a specific mutation helps to determine further strategy not only for a patient, but also to his or her immediate relatives, thereby effectively conducting both secondary and primary prevention of atherosclerosis complications.Brief description. Using the example of patients from the Krasnodar Lipid Center, the relevance of genetic testing and cascade screening is demonstrated. We show problems of delayed diagnosis and low medical adherence, as well as the ways to optimize care for patients with genetic lipid metabolism disorders.Discussion. The rise in the incidence of cardiovascular events at a young age in developed countries prompts the search for more improved screening and diagnostic methods for familial hypercholesterolemia. The optimal age of initiation of lipid-lowering therapy in children with established familial hypercholesterolemia is also discussed. While secondary prevention appears to be clearer, there is still insufficient achievement of low-density lipoprotein cholesterol targets in patients with a previous cardiovascular event.
first_indexed 2024-04-09T20:43:56Z
format Article
id doaj.art-ee59b57750db4c26826390da4ceb07a4
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:43:56Z
publishDate 2021-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-ee59b57750db4c26826390da4ceb07a42023-03-29T21:23:39Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202021-10-01263S10.15829/1560-4071-2021-46103372Familial hypercholesterolemia: case series of a rare conditionO. P. Ishevskaia0A. M. Namitokov1S. V. Kruchinova2E. D. Kosmacheva3Kuban State Medical UniversityKuban State Medical University; Research Institute of the S.V. Ochapovsky Regional Clinical Hospital № 1Kuban State Medical University; Research Institute of the S.V. Ochapovsky Regional Clinical Hospital № 1Kuban State Medical University; Research Institute of the S.V. Ochapovsky Regional Clinical Hospital № 1Introduction. Cardiovascular events at a young age are often the first manifestation of a genetic disorder such as familial hypercholesterolemia. High cholesterol levels, xanthomas and xanthelasmas, as well as a positive family history of cardiovascular disease, make it possible to identify a group of patients subject to genetic research. The identification of a specific mutation helps to determine further strategy not only for a patient, but also to his or her immediate relatives, thereby effectively conducting both secondary and primary prevention of atherosclerosis complications.Brief description. Using the example of patients from the Krasnodar Lipid Center, the relevance of genetic testing and cascade screening is demonstrated. We show problems of delayed diagnosis and low medical adherence, as well as the ways to optimize care for patients with genetic lipid metabolism disorders.Discussion. The rise in the incidence of cardiovascular events at a young age in developed countries prompts the search for more improved screening and diagnostic methods for familial hypercholesterolemia. The optimal age of initiation of lipid-lowering therapy in children with established familial hypercholesterolemia is also discussed. While secondary prevention appears to be clearer, there is still insufficient achievement of low-density lipoprotein cholesterol targets in patients with a previous cardiovascular event.https://russjcardiol.elpub.ru/jour/article/view/4610familial hypercholesterolemiacascade screeningacute coronary syndromecase report
spellingShingle O. P. Ishevskaia
A. M. Namitokov
S. V. Kruchinova
E. D. Kosmacheva
Familial hypercholesterolemia: case series of a rare condition
Российский кардиологический журнал
familial hypercholesterolemia
cascade screening
acute coronary syndrome
case report
title Familial hypercholesterolemia: case series of a rare condition
title_full Familial hypercholesterolemia: case series of a rare condition
title_fullStr Familial hypercholesterolemia: case series of a rare condition
title_full_unstemmed Familial hypercholesterolemia: case series of a rare condition
title_short Familial hypercholesterolemia: case series of a rare condition
title_sort familial hypercholesterolemia case series of a rare condition
topic familial hypercholesterolemia
cascade screening
acute coronary syndrome
case report
url https://russjcardiol.elpub.ru/jour/article/view/4610
work_keys_str_mv AT opishevskaia familialhypercholesterolemiacaseseriesofararecondition
AT amnamitokov familialhypercholesterolemiacaseseriesofararecondition
AT svkruchinova familialhypercholesterolemiacaseseriesofararecondition
AT edkosmacheva familialhypercholesterolemiacaseseriesofararecondition